Community pharmacists optimising treatment for patients with psoriasis

Not Applicable

Completed

• Conditions: Topic: Primary Care; Subtopic: Not Assigned; Disease: All Diseases; Skin and Connective Tissue Diseases

• Registration Number: ISRCTN67700775
• Lead Sponsor: Robert Gordon University (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-05-22
• Last Update Posted: 18 April 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Patients aged over 18 with a diagnosis of chronic plaque psoriasis currently prescribed topical treatment
2. Male & Female
3. Lower Age Limit: 18 no age limit or unit specified

Exclusion Criteria

Patients under 18 years, prescribed oral therapy or receiving phototherapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pedesi; Timepoint(s): at follow-up after 6 weeks

Secondary Outcome Measures

Name	Time	Method
Dermatology quality of life index (DLQI); Timepoint(s): 6 weeks, at the follow-up appointment; sapasi; Timepoint(s): 6 weeks, at follow-up appointment